Plante Moran Financial Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Hold |
0
| – | – | – | 877 |
|
2023
Q1 | – | Sell |
-7,911
| Closed | -$95.2K | – | 900 |
|
2022
Q4 | $95.2K | Hold |
7,911
| – | – | 0.01% | 235 |
|
2022
Q3 | $51K | Hold |
7,911
| – | – | 0.01% | 301 |
|
2022
Q2 | $36K | Buy |
7,911
+331
| +4% | +$1.51K | 0.01% | 358 |
|
2022
Q1 | $66K | Hold |
7,580
| – | – | 0.01% | 288 |
|
2021
Q4 | $108K | Hold |
7,580
| – | – | 0.02% | 240 |
|
2021
Q3 | $167K | Hold |
7,580
| – | – | 0.04% | 211 |
|
2021
Q2 | $101K | Buy |
+7,580
| New | +$101K | 0.02% | 247 |
|
2017
Q4 | – | Sell |
-300
| Closed | -$3K | – | 907 |
|
2017
Q3 | $3K | Hold |
300
| – | – | ﹤0.01% | 704 |
|
2017
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 752 |
|
2017
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 798 |
|
2016
Q4 | $2K | Hold |
300
| – | – | ﹤0.01% | 860 |
|
2016
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 844 |
|
2016
Q2 | $3K | Hold |
300
| – | – | ﹤0.01% | 732 |
|
2016
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 738 |
|
2015
Q4 | $3K | Hold |
300
| – | – | ﹤0.01% | 826 |
|
2015
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 662 |
|
2015
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 682 |
|
2015
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 673 |
|
2014
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 787 |
|
2014
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 748 |
|
2014
Q2 | $3K | Hold |
300
| – | – | ﹤0.01% | 729 |
|
2014
Q1 | $4K | Buy |
+300
| New | +$4K | ﹤0.01% | 500 |
|